{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:40:52Z","timestamp":1782369652242,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["126"],"award-info":[{"award-number":["126"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007460","name":"Arvid Nilssons Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["668532"],"award-info":[{"award-number":["668532"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["670261"],"award-info":[{"award-number":["670261"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.atherosclerosis.2022.03.026","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:44:42Z","timestamp":1648604682000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [64Cu]Cu-DOTA-AE105 positron emission tomography (PET)"],"prefix":"10.1016","volume":"352","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-2075","authenticated-orcid":false,"given":"Harshvardhan A.","family":"Khare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1473-5887","authenticated-orcid":false,"given":"Kristina B.V.","family":"D\u00f8ssing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-2347","authenticated-orcid":false,"given":"Lars","family":"Ringgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-8372","authenticated-orcid":false,"given":"Esben","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-1179","authenticated-orcid":false,"given":"Laerke","family":"Urbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sillesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus S.","family":"Ripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-4546","authenticated-orcid":false,"given":"Tina","family":"Binderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune F.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.atherosclerosis.2022.03.026_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/pros.21306","article-title":"Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer","volume":"71","author":"Almasi","year":"2011","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2022.03.026_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cpf.12037","article-title":"Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications","volume":"33","author":"Persson","year":"2013","journal-title":"Clin. Physiol. Funct. Imag."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2022.03.026_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nucmedbio.2013.03.001","article-title":"First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts","volume":"40","author":"Persson","year":"2013","journal-title":"Nucl. Med. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-1002608","article-title":"Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator","volume":"17","author":"Ploug","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1381612043453559","article-title":"The urokinase plasminogen activator system: role in malignancy","volume":"10","author":"Duffy","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2022.03.026_bib6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.2174\/138161211796718233","article-title":"Clinical applications of the urokinase receptor (uPAR) for cancer patients","volume":"17","author":"Boonstra","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2022.03.026_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1160\/TH05-01-0054","article-title":"Plasminogen activation and cancer","volume":"93","author":"Dan\u00f8","year":"2005","journal-title":"Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2011.10.044","article-title":"The urokinase system in the pathogenesis of atherosclerosis","volume":"222","author":"Fuhrman","year":"2012","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2022.03.026_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","article-title":"Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions","volume":"15","author":"Steins","year":"2004","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2022.03.026_bib10","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1161\/STROKEAHA.112.664094","article-title":"Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque","volume":"43","author":"Andreas","year":"2012","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2022.03.026_bib11","first-page":"459","article-title":"Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis","volume":"22","author":"Svensson","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"6917","key":"10.1016\/j.atherosclerosis.2022.03.026_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2022.03.026_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","article-title":"Macrophage diversity and polarization in atherosclerosis: a question of balance","volume":"29","author":"Mantovani","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9582430","article-title":"Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis","volume":"2016","author":"Bobryshev","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3389\/fimmu.2017.01921","article-title":"New insights into the immunobiology of mononuclear phagocytic cells and their relevance to the pathogenesis of cardiovascular diseases","volume":"8","author":"Sanmarco","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.RES.75.1.181","article-title":"Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion","volume":"75","author":"Galis","year":"1994","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2022.03.026_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1139\/Y08-113","article-title":"Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator this article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Sp","volume":"87","author":"Tkachuk","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2 SUPPL. 1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.111.187021","article-title":"Vascular remodeling in hypertension: mechanisms and treatment","volume":"59","author":"Schiffrin","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib19","first-page":"85","article-title":"Vascular remodeling in hypertension","author":"Humar","year":"2005","journal-title":"Hypertension: Principl. Pract."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib20","doi-asserted-by":"crossref","first-page":"C481","DOI":"10.1152\/ajpcell.00147.2020","article-title":"Extracellular matrix dynamics in vascular remodeling","volume":"319","author":"Ma","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2022.03.026_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hq0701.093685","article-title":"Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis","volume":"21","author":"Pepper","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"DEC","key":"10.1016\/j.atherosclerosis.2022.03.026_bib22","first-page":"1","article-title":"Mechanisms of arterial remodeling: lessons from genetic diseases","volume":"3","author":"Van Varik","year":"2012","journal-title":"Front. Genet."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2022.03.026_bib23","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM199405193302008","article-title":"The emerging concept of vascular remodeling","volume":"330","author":"Gibbons","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2967\/jnumed.116.178970","article-title":"Safety, dosimetry, and tumor detection ability of (68)Ga-NOTA-AE105: first-in-human study of a novel radioligand for uPAR PET imaging","volume":"58","author":"Skovgaard","year":"2017","journal-title":"J. Nucl. Med. : Off. Publ., Soc. Nucl. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2022.03.026_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40336-016-0197-4","article-title":"PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives","volume":"4","author":"Skovgaard","year":"2016","journal-title":"Clin. Transl. Imag."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2022.03.026_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.12956","article-title":"First-in-human uPAR PET: imaging of cancer aggressiveness","volume":"5","author":"Persson","year":"2015","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nucmedbio.2013.12.007","article-title":"Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging","volume":"41","author":"Persson","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib28","article-title":"Urokinase plasminogen activator receptor (uPAR) PET\/MRI of prostate cancer for non-invasive evaluation of aggressiveness: a prospective phase II clinical trial comparing with Gleason score","volume":"120","author":"Fosb\u00f8l","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2022.03.026_bib29","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/ATVBAHA.111.237081","article-title":"Activation OF T lymphocytes IN atherosclerotic plaques","volume":"31","author":"Grivel","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jim.2014.12.010","article-title":"Fluorescent activated cell sorting: an effective approach to study dendritic cell subsets in human atherosclerotic plaques","volume":"417","author":"Van Brussel","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2017.10.003","article-title":"Ex vivo culture of human atherosclerotic plaques: a model to study immune cells in atherogenesis","volume":"267","author":"Lebedeva","year":"2017","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2022.03.026_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/0100-3984.2015.0235","article-title":"Coronary artery calcium score: current status","volume":"50","author":"Neves","year":"2017","journal-title":"Radiol. Bras."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2022.03.026_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2008.07.072","article-title":"Coronary calcium predicts events better with absolute calcium scores than age-sex-race\/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"53","author":"Budoff","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101380","article-title":"7-Ketocholesterol in disease and aging","volume":"29","author":"Anderson","year":"2020","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2022.03.026_bib36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCRESAHA.117.311049","article-title":"Association of plasma 7-ketocholesterol with cardiovascular outcomes and total mortality in patients with coronary artery disease","volume":"120","author":"Song","year":"2017","journal-title":"Circ. Res."},{"issue":"6766","key":"10.1016\/j.atherosclerosis.2022.03.026_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35003221","article-title":"Interferon-\u03b3 elicits arteriosclerosis in the absence of leukocytes","volume":"403","author":"Tellides","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2022.03.026_bib38","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/ATVBAHA.115.305464","article-title":"Interferons as essential modulators of atherosclerosis","volume":"35","author":"Boshuizen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2022.03.026_bib39","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.108.823740","article-title":"Functional role of CD11c(+) monocytes in atherogenesis associated with hypercholesterolemia","volume":"119","author":"Wu","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep42665","article-title":"Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue","volume":"7","author":"Wouters","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2022.03.026_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MOL.0b013e328363d298","article-title":"Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms","volume":"24","author":"Koltsova","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib42","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI93025","article-title":"CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis","volume":"128","author":"Guo","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.03.026_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71110-x","article-title":"CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques","volume":"10","author":"Bengtsson","year":"2020","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2022.03.026_bib45","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2022.03.026_bib46","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.114.305067","article-title":"64Cu-DOTATATE PET\/MRI for detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy","volume":"35","author":"Pedersen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.116.180430","article-title":"Head-to-Head comparison of 64 Cu-DOTATATE and 64 Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"Johnbeck","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2022.03.026_bib48","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2967\/jnumed.115.161216","article-title":"64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients","volume":"56","author":"Malmberg","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2022.03.026_bib49","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2967\/jnumed.111.093724","article-title":"Investigating vulnerable atheroma using combined 18F-FDG PET\/CT angiography of carotid plaque with immunohistochemical validation","volume":"52","author":"Menezes","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2022.03.026_bib50","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/STROKEAHA.119.025422","article-title":"Carotid plaque inflammation imaged by 18F-fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke","volume":"50","author":"KP","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2022.03.026_bib51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.23553","article-title":"Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence","volume":"71","author":"Marnane","year":"2012","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2022.03.026_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12149-012-0679-z","article-title":"Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects","volume":"27","author":"Ryu","year":"2013","journal-title":"Ann. Nucl. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2022.03.026_bib53","first-page":"1250","article-title":"Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV events","volume":"6","author":"Figueroa","year":"2013","journal-title":"JACC (J. Am. Coll. Cardiol.): Cardiovasc. Imag."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2022.03.026_bib54","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.celrep.2017.12.011","article-title":"Tumor-associated macrophages derived from circulating inflammatory monocytes degrade collagen through cellular uptake","volume":"21","author":"Madsen","year":"2017","journal-title":"Cell Rep."},{"issue":"9918","key":"10.1016\/j.atherosclerosis.2022.03.026_bib55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2022.03.026_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2967\/jnumed.109.070672","article-title":"In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET\/CT: correlation with coronary calcium burden and risk factors","volume":"51","author":"Rominger","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.atherosclerosis.2022.03.026_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.790405","article-title":"Effect of 26 Weeks of Liraglutide treatment on coronary artery inflammation in type 2 diabetes quantified by [64Cu]Cu-DOTATATE PET\/CT: results from the LIRAFLAME trial","volume":"12","author":"Jensen","year":"2021","journal-title":"Front. Endocrinol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:27:04Z","timestamp":1762187224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":57,"alternative-id":["S0021915022001599"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.03.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [64Cu]Cu-DOTA-AE105 positron emission tomography (PET)","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}